We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
A roadmap outlining the intended timelines for delivering a future regulatory framework for medical devices and an intended policy on international recognition.
This leaflet is for pregnant women whose baby may have anencephaly. It can help women talk through the next stages of their care with health professionals.
Easy read versions of the NHS Constitution, which establishes the principles and values of the NHS in England.
Guidance on out of specification investigations, including definitions and laboratory analysis and phase I,II and III investigations.
This leaflet provides information on having a colonoscopy if further tests are needed after using the NHS bowel cancer screening test kit.
Advice and guidance on the health needs of migrant patients for healthcare practitioners.
An easy read leaflet about breast screening.
How the MHRA makes decisions on when a product is a medical device (borderline products), and which risk class should apply to a medical device.
How to get a parallel import licence for your medicine in the UK, including pharmacovigilance requirements and submitting your application.
What NCARDRS does, the benefits of registering, and how we look after your information.
How the MHRA makes decisions on what is a medicinal product (borderline products).
This framework focuses on carbapenemase-producing Enterobacterales that spread rapidly in healthcare settings.
These documents remind health services of their duties to safeguard adults.
Information for prospective growers of low THC cannabis (industrial hemp), for the production of seed and fibre only.
The processes for managing safety incidents in the NHS screening programmes.
This revised reference guide gives information and advice on how the 1983 Mental Health Act operates.
Data on the real-world efficacy of the COVID-19 vaccines.
This overview is aimed at professionals working in the NHS newborn blood spot (NBS) screening programme.
How to change the ownership from one marketing authorisation (MA) holder to another.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).